TRICALS satellite meeting
June 24, 2026
A TRICALS satellite meeting at the ENCALS meeting: insights in recent and upcoming trial results
This year marks a special milestone for TRICALS, as we will be hosting a satellite meeting during the ENCALS meeting on Wednesday morning, June 24, from 8.15 a.m. to 11.50 p.m. The purpose of this meeting is to present and discuss recent trial results and to exchange insights on their implications. In addition, we would like to highlight ongoing/upcoming studies.
Join us for a morning filled with interesting talks and discussions about the current clinical trial landscape in ALS.
Secure your spot and register now!
Register for the meeting via the button below, or scroll to the end of this page
Preliminary programme
08:15-08:45: Breakfast, networking and walk-in
08:45-09:00: Opening by Prof. Leonard van den Berg
09:00-10:00: Study results: Magnet lithium, Quralis, argenx, AL-S pharma, Corcept, Neurosense
10:00-10:15: Bio break
10:15-11:05: Study updates: VectorY, Leal Therapeutics Inc., Axoltis, Ionis, Trace Neuroscience, Zydus Therapeutics Inc., NuraBio, Eli Lilly, ProjenX
11:05-11:30: Panel discussion with Group 2 presenters
11:30-11:50: PREVAiLS study update
Location
Buenos Aires – Habana – Mexico room
IFEMA Palacio Municipal (ENCALS congress location)
Contact
Questions? Email events@tricals.org
